Abstract
Objectives: To investigate the outcome of endovascular treatment in acute thromboembolic occlusion of the superior mesenteric artery.
 Methodology: Eighteen consecutive patients who underwent endovascular treatment in acute thromboembolic occlusion of the superior mesenteric artery from January 2013 to September 2019 were included in the study. Thirty-day mortality, avoidance of laparotomy, angiographic success, length of hospital stay and complication rates were assessed.
 Results: The patients were 46 to 87 (70.5 ± 13.0) year-old, and 9 (50%) were male. In our study, 30-day mortality rate was 33.3%. The remaining patients were discharged uneventfully. Our complete and partial success rates was 61.1% and 38.9% respectively on angiographic assessment. The mean length of hospital stay was 7.8 ± 5.0 days in the remaining patients. Short bowel syndrome, respiratory failure requiring mechanical ventilation support or renal failure requiring dialysis were not observed in remaining patients. Laparotomy was needed for eight patients after endovascular treatment.
 Conclusion: The data showed that endovascular treatment is a technically feasible, effective and reliable alternative treatment method in a selected group of patients with acute thromboembolic occlusion of the superior mesenteric artery.
Highlights
Acute mesenteric ischemia is a life-threatening disease, resulting in ischemia, cellular damage and necrosis as a result of sudden cessation of the intestines
Most of the acute mesenteric ischemia is caused by mesenteric arterial embolism (50%) and mesenteric arterial thrombosis (15–25%).[2,3]
A total of 18 patients (9 males) undergoing initial endovascular intervention due to acute thromboembolic occlusion of the superior mesenteric artery (SMA) were included in the study
Summary
Acute mesenteric ischemia is a life-threatening disease, resulting in ischemia, cellular damage and necrosis as a result of sudden cessation of the intestines. It is rarely, in-hospital mortality is still very high and could reach up to 93%.1. Because superior mesenteric artery (SMA) has a large diameter and low take-off angle from the aorta, it is most affected. The majority of emboli is observed 3 to 10 cm distal to the origin of the SMA. Thrombi usually occurs at the origin of SMA. Thrombosis of the SMA is usually linked to pre-existing chronic atherosclerotic disease leading to stenosis. We assessed the outcome of endovascular treatment in acute thromboembolic occlusion of the SMA
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
